McElhaugh Michael J. 4
4 · Arbutus Biopharma Corp · Filed Feb 10, 2021
Insider Transaction Report
Form 4
McElhaugh Michael J.
DirectorInterim President & CEO
Transactions
- Sale
Common Stock
2021-02-09$5.00/sh−20,000$100,000→ 1,307,457 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2020.